At the news
? NEUTRALIMPACT 2/10 144 filed Nov 2, 2026 at 16:37 ET
Adam Crystal, an officer of Tango Therapeutics, filed a Form 144 notice of intent to sell 20,000 shares of common stock, valued at approximately $454,400, on November 2, 2026. The shares are to be acquired through the exercise of stock options, and the sale is part of a pre-existing 10b5-1 trading plan, with prior monthly sales of 27,000 shares each in August, September, and October 2026. This is a routine insider sale under a plan, not a discretionary signal.
- Insider Adam Crystal (Officer) filed Form 144 to sell 20,000 shares of Tango Therapeutics common stock.
- Estimated sale value: $454,400 (based on $22.72 per share, derived from the filing's total value and share count).
- Shares to be sold are acquired via exercise of stock options.
- Sale is part of a 10b5-1 trading plan; prior sales under the same plan: 27,000 shares on 10/01/2026 ($660,797), 09/01/2026 ($603,910), and 08/03/2026 ($735,518).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access